Stella Pharma (TSE:4888) Retained Earnings : 円-268.7 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Stella Pharma Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Stella Pharma's retained earnings for the quarter that ended in Sep. 2024 was 円-268.7 Mil.

Stella Pharma's quarterly retained earnings declined from Dec. 2023 (円-469.6 Mil) to Mar. 2024 (円-763.7 Mil) but then increased from Mar. 2024 (円-763.7 Mil) to Sep. 2024 (円-268.7 Mil).

Stella Pharma's annual retained earnings increased from Mar. 2022 (円-2,636.9 Mil) to Mar. 2023 (円-778.8 Mil) and increased from Mar. 2023 (円-778.8 Mil) to Mar. 2024 (円-763.7 Mil).

Stella Pharma Retained Earnings Historical Data

The historical data trend for Stella Pharma's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Pharma Retained Earnings Chart

Stella Pharma Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Retained Earnings

Get a 7-Day Free Trial

-1,209.97

-1,869.21

-2,636.93

-778.82

-763.75

Stella Pharma Quarterly Data
	Mar19	Mar20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Retained Earnings	Get a 7-Day Free Trial												-944.52	-305.86	-469.56	-763.75	-268.72

Stella Pharma Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Stella Pharma (TSE:4888) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Stella Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stella Pharma Corp (TSE:4888) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-2-7 Korai-bashi, Chuo-ku, Osaka Prefecture, Osaka, JPN, 541-0043

Website

https://stella-pharma.co.jp

Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.

Stella Pharma Headlines

No Headlines